Kuroda Y, Arima S, Ohsato K, Ohkuma R, Fukuyama N, Yamanouchi A, Hisatsugu T, Yamamoto H, Nakamura Y, Abe R
1st Dept. of Surgery, School of Medicine, University of Occupational and Environmental Health, Kita-Kyushu, Japan.
Gan To Kagaku Ryoho. 1992 Oct;19(12):2025-30.
The usefulness of pre- and post-operative adjuvant chemotherapy in colorectal cancer patients was studied by the North Kyushu Co-operative Study Group for Cancer Chemotherapy (21 participating institutions). Comparisons were made among group I given a tegafur suppository preoperatively+tegafur oral preparation postoperatively, group II given a tegafur suppository preoperatively+UFT oral preparation postoperatively and group III given a tegafur oral preparation postoperatively. No differences were seen in the incidence of postoperative complications depending on whether or not tegafur suppositories were administered preoperatively. There were also no differences in the symptom or incidence of side effects due to postoperative administration of tegafur or UFT. In a study of 5-FU concentration in the lymph nodes due to preoperative tegafur administration and recurrences, the concentration of 5-FU was significantly higher in the lymph nodes of cases without recurrences than in those with recurrences, and it was suggested that a relation exists between the concentration of agent and recurrences. The concentration of 5-FU in the lymph nodes of Dukes B patients was significantly higher in cases without recurrences than in those with recurrences. The non-recurrence rate (healthy rate) was better in the group given UFT postoperatively than in that administered tegafur postoperatively although the difference was not significant.
北九州癌症化疗合作研究组(21个参与机构)研究了术前和术后辅助化疗在结直肠癌患者中的有效性。对三组患者进行了比较,第一组患者术前给予替加氟栓剂,术后给予替加氟口服制剂;第二组患者术前给予替加氟栓剂,术后给予优福定口服制剂;第三组患者术后给予替加氟口服制剂。术前是否给予替加氟栓剂,术后并发症的发生率并无差异。术后给予替加氟或优福定所产生的症状或副作用发生率也没有差异。在一项关于术前给予替加氟后淋巴结中5-氟尿嘧啶浓度与复发情况的研究中,无复发病例淋巴结中的5-氟尿嘧啶浓度显著高于复发病例,提示药物浓度与复发之间存在关联。Dukes B期患者无复发病例淋巴结中的5-氟尿嘧啶浓度显著高于复发病例。术后给予优福定的组的无复发率(健康率)比术后给予替加氟的组更好,尽管差异不显著。